Fig. 13

Compactness analysis of the lead compounds and target protein. a The compactness of the methotrexate-CerS6 complex as Rg. b The compactness of the myriocin-CerS6 complex as Rg. c The compactness of the Eliglustat-CerS6 complex as Rg. d Represents the compactness of the statin-CerS6 complex as Rg.